Tissue Repair Gel in Venous Leg Ulcers in AU/US (NCT06707103)
A Phase 3 Randomized, Parallel Group, Double-Blind Study to Evaluate the Efficacy, Tolerability, and Safety of TR987® 0.1% Gel Versus Standard of Care in the Treatment of Chronic Venous Insufficiency Leg Ulcers (VLU)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It will also provide additional information about the safety of drug TR987 0.1% gel.
Who can join: Review the eligibility criteria below.
Location: Clincial Research Site 92 — Jacksonville, Florida
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (12 Sites)
- Clincial Research Site 92 — Jacksonville, Florida
- Clincial Research Site 77 — Clinton Twp, Michigan
- Clincial Research Site 82 — Lake Success, New York
- Clinical Research Site 76 — Fort Worth, Texas
- Clincial Research Site 62 — Camperdown, New South Wales
- Clinical Research Site 84 — Kogarah, New South Wales
- Clincial Research Site 78 — Orange, New South Wales
- Clincial Research Site 85 — Sydney, New South Wales
- Clincial Research Site 74 — Bendigo, Victoria
- Clincial Research Site 60 — Ivanhoe, Victoria
- Clincial Research Site 65 — Shepparton, Victoria
- Clincial Research Site 75 — Nedlands, Western Australia
📞 Contact the Study Coordinator
Phone: (+61) 280 034 554
Email: anhthu.nguyen@trtherapeutics.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Venous Leg Ulcer
- Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III) — Hialeah, Florida
- Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers — Los Angeles, California
- LUT017 Gel for Venous Leg Ulcers and Chronic Non-Healing Skin Wounds in Adults — Los Angeles, California
- Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers. — Monroeville, Pennsylvania
- Tissue Repair Gel in Venous Leg Ulcers (US) — Tucson, Arizona
- Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers — Alexandria, Louisiana
Explore by condition: All Venous Leg Ulcer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.